bromodeoxyuridine has been researched along with Maxillary Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanami, S; Hirayama, T; Lian, SL; Nagai, T; Sakaizumi, K; Tomita, O | 1 |
| Kawamoto, K; Kumazawa, H; Kumazawa, T; Matsumura, H; Wada, Y; Yamashita, T | 1 |
| Nakai, Y; Nakajima, T; Onoyama, Y; Sugiyama, M; Tamura, T; Uekawa, M | 1 |
| Takahashi, H | 1 |
| Kawamoto, K; Kumazawa, T; Matsumura, H; Oka, S; Wada, Y; Yamashita, T | 1 |
| Kawamoto, K; Kumazawa, T; Kuriyama, H; Matsumura, H; Oka, S; Wada, Y; Yamashita, T | 1 |
| Kuroda, Y; Monju, T; Ota, F; Takahashi, M; Tanaka, Y | 1 |
7 other study(ies) available for bromodeoxyuridine and Maxillary Neoplasms
| Article | Year |
|---|---|
The effects of "BAR" therapy on oral malignant tumors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Carcinoma, Squamous Cell; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Neoplasms; Middle Aged; Mouth Floor; Mouth Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tongue Neoplasms | 1978 |
Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and peplomycin).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; Flow Cytometry; G2 Phase; Humans; In Vitro Techniques; Male; Maxillary Neoplasms; Middle Aged; Peplomycin; S Phase; Tumor Cells, Cultured | 1992 |
Synergistic effects of irradiation and hyperthermia on established cell lines derived from maxillary carcinoma. Report II.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Combined Modality Therapy; Humans; Hyperthermia, Induced; In Vitro Techniques; Maxillary Neoplasms; S Phase; Tumor Cells, Cultured | 1991 |
[A combined therapy for maxillary cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Combined Modality Therapy; Female; Fluorouracil; Humans; Injections, Intra-Arterial; Lymph Node Excision; Male; Maxillary Neoplasms; Middle Aged; Survival Rate | 1991 |
Clinical evaluation for the mechanism of cisplatin with bromodeoxyuridine by flow cytometry and clinico-histological study.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; DNA; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Humans; Kinetics; Male; Maxillary Neoplasms; Middle Aged; Propidium; Thiocyanates | 1989 |
[Clinical evaluation by flow cytometry in the mechanism of action of CDDP with arterial injection of bromo deoxyuridine].
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cisplatin; Flow Cytometry; Humans; Injections, Intra-Arterial; Interphase; Male; Maxillary Neoplasms; Middle Aged | 1987 |
[Application of radiosensitizer, 5-bromodeoxyuridine, to head and neck tumors].
Topics: Bromodeoxyuridine; Fluorouracil; Humans; Injections, Intra-Arterial; Iodine Isotopes; Male; Maxillary Neoplasms; Mouth Mucosa; Radiation-Sensitizing Agents; Time Factors; Tongue Neoplasms | 1969 |